The tumors were subjected to immunohistochemistry experiments, and the results showed that compared to the control group, the expression of Ki67 in the Sch B-treated group was reduced (Figure 6D), suggesting that Sch B can inhibit the growth of HCC tumors. The gene discussed is MKI67; the disease is hepatocellular carcinoma.